Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Jun 2, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The "Fight Fatigue" clinical trial is looking at a new way to help adults with end-stage kidney disease (ESKD) who are receiving dialysis feel less tired. The study combines progressive muscle relaxation (a technique to help your muscles relax) with walking to see if these activities can reduce fatigue, which is a common problem for people with ESKD. This trial is currently not recruiting participants, but it aims to find out how acceptable and feasible this approach is for those who are eligible.
To participate, you must be between the ages of 65 and 74, have been diagnosed with ESKD and been on dialysis for at least three months, and experience fatigue that rates at least a 4 on a scale from 0 to 10. You should be able to walk one block and have a cell phone that can receive text messages. However, if your doctor does not agree with your participation, or if you have certain medical conditions that would prevent you from safely participating, you may not be eligible. If you join the study, you can expect to engage in muscle relaxation exercises and walking, which may help improve your energy levels and overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of ESKD diagnosis and receiving hemodialysis for at least 3 months
- • Can read and speak English
- • Fatigue measured via visual analogue scale, score ≥4 over the last week
- • Able to stand and walk one block
- • Has a cell phone that can receive text messages
- Exclusion Criteria:
- • Patient's nephrologist refuses for them to participate
- • Unstable angina
- • Unstable pulmonary disease or pulmonary symptoms that preclude participation
- • Lower-extremity amputation without prosthetic (BKA, AKA) -Orthopedic or neurologic condition that would preclude walking or tensing/releasing of muscles-
- • Cognitive impairment that, in the judgement of the research team, precludes trial participation
- • Participation in the formative phase of the development of Fight Fatigue
About University Of Illinois At Chicago
The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported